Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02709512
Title Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ATOMIC)
Acronym ATOMIC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Polaris Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | AUS


No variant requirements are available.